genetics

STAT Summit By Megan Molteni

Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too

Health By Megan Molteni

World Health Organization advisers urge global effort to regulate genome editing

In the Lab By Megan Molteni

Landmark gene therapy trial points to a wider window to alter course of rare disease

Health By Megan Molteni

Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard

In the Lab By Erika Check Hayden

Could editing the genomes of bats prevent future coronavirus pandemics? Two scientists think it’s worth a try

In the Lab By Megan Molteni

With a souped up synthetic genome, scientists make bacteria impervious to viral attack

In the Lab By Matthew Herper

Researchers claim they have sequenced the entirety of the human genome — including the missing parts

Health By Elizabeth Cooney

‘We shouldn’t leave anybody behind’: Inequities in cancer genomics undercut promise of precision medicine

Exclusive By Megan Molteni and Katie Palmer

From two unusual organ donations, scientists garner a unique trove of single-cell genetic data

Special Report By Andrew Joseph

‘It’s not a cure’: A gene therapy is opening a new chapter for children, but challenges endure

Health By Megan Molteni

With engineered proteins, scientists use optogenetics for the first time to help a blind patient see again

Politics By Megan Molteni

California could become first state to mandate biosecurity screening by mail-order DNA companies

Biotech By Matthew Herper

At Illumina, the ‘era of the genome’ has arrived. But what role will the company play?

In the Lab By Associated Press

AIDS virus used in gene therapy to fix ‘bubble baby’ disease

Pharmalot By Ed Silverman

Dutch advisory group says Zolgensma shouldn’t be covered unless Novartis halves price

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Vaccine riches, patent waivers, & a gene therapy for aging

Exclusive By Megan Molteni

Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims

In the Lab By Kate Sheridan

HHS to prioritize newborn screening programs’ pipette tip orders

Exclusive By Erin Brodwin

With $12 million in new funding, data-syncing platform Seqster takes aim at health records

Biotech By Megan Molteni

Beam Therapeutics unveils new CRISPR base editing tool to target the sickle cell mutation

First Opinion By Ilaria Capua

Looking back at 15 years of sharing viral genomes to forge ahead

Health By Andrew Joseph

Huntington’s community grieves not just one therapeutic setback, but two

Health By Eric Boodman

Virtual Event: What gene-targeted therapies mean for patients with cancer

First Opinion By James Crawford, Jonathan Slotkin, and Meg Wyatt

To stem the pandemic, the U.S. needs a national Covid-19 genomic sequencing effort

Biotech By Damian Garde

STAT+ Conversations: A conversation on the future of gene therapy